Cullen Alexis E, Lindsäter Elin, Rahman Syed, Taipale Heidi, Tanskanen Antti, Mittendorfer-Rutz Ellenor, Helgesson Magnus
Department of Clinical Neuroscience, Division of Insurance Medicine, Karolinska Institutet, Stockholm, Sweden; and Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK.
Department of Clinical Neuroscience, Division of Psychology, Karolinska Institutet, Stockholm, Sweden.
BJPsych Open. 2023 Feb 28;9(2):e40. doi: 10.1192/bjo.2023.8.
Psychological and pharmacological therapies are the recommended first-line treatments for common mental disorders (CMDs) but may not be universally accessible or utilised.
To determine the extent to which primary care patients with CMDs receive treatment and the impact of sociodemographic, work-related and clinical factors on treatment receipt.
National registers were used to identify all Stockholm County residents aged 19-64 years who had received at least one CMD diagnosis (depression, anxiety, stress-related) in primary care between 2014 and 2018. Individuals were followed from the date of their first observed CMD diagnosis until the end of 2019 to determine treatment receipt. Associations between patient factors and treatment group were examined using multinomial logistic regression.
Among 223 271 individuals with CMDs, 30.6% received pharmacotherapy only, 16.5% received psychological therapy only, 43.1% received both and 9.8% had no treatment. The odds of receiving any treatment were lower among males (odds ratio (OR) range = 0.76 to 0.92, 95% CI 0.74 to 0.95), individuals born outside of Sweden (OR range = 0.67 to 0.93, 95% CI 0.65 to 0.99) and those with stress-related disorders only (OR range = 0.21 to 0.51, 95% CI 0.20 to 0.53). Among the patient factors examined, CMD diagnostic group, prior treatment in secondary psychiatric care and age made the largest contributions to the model (R difference: 16.05%, 1.72% and 1.61%, respectively).
Although over 90% of primary care patients with CMDs received pharmacological and/or psychological therapy, specific patient groups were less likely to receive treatment.
心理治疗和药物治疗是常见精神障碍(CMD)推荐的一线治疗方法,但并非普遍可得或被采用。
确定患有CMD的初级保健患者接受治疗的程度,以及社会人口学、工作相关因素和临床因素对治疗接受情况的影响。
利用国家登记册识别出2014年至2018年间在初级保健中至少接受过一次CMD诊断(抑郁症、焦虑症、与压力相关的疾病)的所有19至64岁的斯德哥尔摩县居民。从首次观察到CMD诊断之日起对个体进行随访,直至2019年底,以确定治疗接受情况。使用多项逻辑回归分析患者因素与治疗组之间的关联。
在223271名患有CMD的个体中,30.6%仅接受药物治疗,16.5%仅接受心理治疗,43.1%两者都接受,9.8%未接受治疗。男性(优势比(OR)范围=0.76至0.92,95%CI 0.74至0.95)、在瑞典境外出生的个体(OR范围=0.67至0.93,95%CI 0.65至0.99)以及仅患有与压力相关疾病的个体(OR范围=0.21至0.51,95%CI 0.20至0.53)接受任何治疗的几率较低。在所检查的患者因素中,CMD诊断组、二级精神科护理中的既往治疗和年龄对模型的贡献最大(R差异分别为16.05%、1.72%和1.61%)。
尽管超过90%的患有CMD的初级保健患者接受了药物和/或心理治疗,但特定患者群体接受治疗的可能性较小。